Forklift OperatorHome Depot Glastonbury, CT Apr 2009 to Dec 2012 Freight Team AssociateHome Depot Manchester, CT Jul 2011 to Mar 2012 CashierHome Depot East Hartford, CT Jan 2010 to Feb 2011 Sandwich Artist
Conditions of Pregnancy and Delivery Genital HPV Uncomplicated or Low Risk Pregnancy and Delivery Abnormal Vaginal Bleeding Breast Disorders
Languages:
English Spanish
Description:
Dr. Jenkins graduated from the University of Alabama School of Medicine in 1994. He works in Dublin, OH and 1 other location and specializes in Obstetrics & Gynecology. Dr. Jenkins is affiliated with Dublin Methodist Hospital, Mount Carmel St Anns Hospital, OSU Harding Hospital and Riverside Methodist Hospital.
Dr. Jenkins graduated from the Eastern Virginia Medical School Medical College in 2005. He works in Newport News, VA and 1 other location and specializes in Vascular Surgery. Dr. Jenkins is affiliated with Riverside Regional Medical Center and Sentara Williamsburg Regional Medical Center.
Dr. Jenkins graduated from the University of Alabama School of Medicine in 1994. He works in Birmingham, AL and 2 other locations and specializes in Obstetrics & Gynecology. Dr. Jenkins is affiliated with University Of Alabama Hospital.
Peace Camera LLC Photography · Retail Cameras · Camera Repair · Photographic Equip & Supplies- · Camera & Photographic Supplies Store
421 W Peace St, Raleigh, NC 27603 9198362222, 9198361711
Todd Jenkins
INTEGRATED NETWORK DESIGN, LTD
Todd J. Jenkins
OHIO NORTH LLC
Todd A. Jenkins Principal
Southeastern Camera & Supply Ret Cameras/Photography Supplies
3269 Ml Run, Raleigh, NC 27612
Us Patents
Methods, Systems, And Computer Program Product For Validating Drug Product Package Contents Based On Characteristics Of The Drug Product Packaging System
- Durham NC, US Todd Martin Jenkins - Raleigh NC, US Russell F. Lewis - Dallas TX, US Corey Spencer Martin - Raleigh NC, US Abhishek Ray - New Town NC, US Arthur F. Swanson - Cary NC, US Rongkai Xu - Morganville NJ, US
A method includes receiving an image of a drug product package that contains one or more drug products therein; detecting, using an artificial intelligence engine, characteristics of the image that are associated with a drug product packaging system; and generating a modified image of the drug product package based on characteristics of the drug product packaging system.
Methods, Systems, And Computer Program Product For Removing Extraneous Content From Drug Product Packaging To Facilitate Validation Of The Contents Therein
- Durham NC, US Todd Martin Jenkins - Raleigh NC, US Russell F. Lewis - Dallas TX, US Corey Spencer Martin - Raleigh NC, US Abhishek Ray - New Town NC, US Arthur F. Swanson - Cary NC, US Rongkai Xu - Morganville NJ, US
International Classification:
G06V 20/62 G06T 5/00 G06V 10/82 G16H 70/40
Abstract:
A method includes receiving an image of a drug product package that contains one or more drug products therein, the image including labeling content displayed on a surface thereof; detecting, using an artificial intelligence engine, the labeling content on the surface of the drug product package; and generating a modified image of the drug product package that has the labeling content removed from surface thereof.
Methods, Systems, And Computer Program Product For Validating Drug Product Package Content Using Tiered Evaluation Factors
A method includes receiving a drug product package containing one or more drug products therein; evaluating the one or more drug products contained in the drug product package based on a plurality of drug product evaluation factors, the plurality of drug product evaluation factors including an enhanced scrutiny factor; assigning a validation score to the drug product package based on evaluating the one or more drug products contained in the drug product package, a magnitude of the validation score being greater with decreasing patient risk; and validating the drug product package. Validating the drug product package comprises: validating the drug product package based on a first comparison of the magnitude of the validation score with a first threshold responsive to a presence of the enhanced scrutiny factor and a second comparison of the magnitude of the validation score with a second threshold responsive to an absence of the enhanced scrutiny factor, the first threshold being greater than the second threshold; or identifying the drug product package as requiring manual validation responsive to the presence of the enhanced scrutiny factor.